K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 335.4 INR 0.77% Market Closed
Market Cap: 5.9B INR

Kilitch Drugs (India) Ltd
Pre-Tax Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Kilitch Drugs (India) Ltd
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
K
Kilitch Drugs (India) Ltd
NSE:KILITCH
Pre-Tax Income
₹362.7m
CAGR 3-Years
48%
CAGR 5-Years
348%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Pre-Tax Income
₹75.3B
CAGR 3-Years
20%
CAGR 5-Years
30%
CAGR 10-Years
15%
Cipla Ltd
NSE:CIPLA
Pre-Tax Income
₹70.4B
CAGR 3-Years
25%
CAGR 5-Years
22%
CAGR 10-Years
12%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Pre-Tax Income
₹140.7B
CAGR 3-Years
40%
CAGR 5-Years
53%
CAGR 10-Years
11%
Lupin Ltd
NSE:LUPIN
Pre-Tax Income
₹53.9B
CAGR 3-Years
164%
CAGR 5-Years
39%
CAGR 10-Years
6%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Pre-Tax Income
₹28.8B
CAGR 3-Years
32%
CAGR 5-Years
16%
CAGR 10-Years
4%
No Stocks Found

Kilitch Drugs (India) Ltd
Glance View

Market Cap
5.5B INR
Industry
Pharmaceuticals

Kilitch Drugs (India) Ltd. engages in the manufacture and sale of pharmaceuticals, medicinal chemical, and botanical products. The company is headquartered in Mumbai, Maharashtra. The company is primarily engaged in the development, manufacturing, and marketing of finished dosages. The Company’s products include parenteral solutions, effervescent, nutritional products, and medical device. Its products categories include urinary alkalizer, cephalosporins products, gastroenterology, non steroidal anti-inflammatory drugs (NSAIDs), anticonvulsant/antiepileptic, adrenergic agonist, neurotonic, muscle relaxant/stimulant, aminoglycosides, anti-infective, anti-inflammatory, anti-malarials, anti-hypertensive, anaesthetic, uterine stimulants. Its parenteral solutions include neurotonic, veterinary products, metered nasal drops, vaccines, oncology, and ophthalmic products. Its effervescent products include Roipar, Duregra, And Roivit. The firm offers nutritional products, such as Celtine. The firm also offers medical devices, such as C-Seal.

KILITCH Intrinsic Value
329.45 INR
Overvaluation 2%
Intrinsic Value
Price
K

See Also

What is Kilitch Drugs (India) Ltd's Pre-Tax Income?
Pre-Tax Income
362.7m INR

Based on the financial report for Jun 30, 2025, Kilitch Drugs (India) Ltd's Pre-Tax Income amounts to 362.7m INR.

What is Kilitch Drugs (India) Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
348%

Over the last year, the Pre-Tax Income growth was 119%. The average annual Pre-Tax Income growth rates for Kilitch Drugs (India) Ltd have been 48% over the past three years , 348% over the past five years .

Back to Top